JXSL1800052 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products | Import Drug Application | 2018-11-21 | 昆泰企业管理(上海)有限公司 | Aikunwei Medical Technology (Shanghai) Co Ltd | In Review | 2018-11-20 | view |
JXSL2400011 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2024-01-10 | | | | | view |
JXSL2000237 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2021-01-01 | Daiichi Sankyo, Inc. | Daiichi Sankyo Co Ltd | In Review | 2021-01-01 | view |
JXSB2101068 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2021-10-19 | | | | | view |
JXSL2000037 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products | Import Drug Application | 2020-04-15 | Daiichi Sankyo, Inc. | Daiichi Sankyo Co Ltd | In Review | 2020-04-14 | view |
JXSB2200120 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2022-09-19 | | | | | view |
JXSB2200012 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2022-01-25 | | | | | view |
JXSL2000178 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2020-10-14 | Daiichi Sankyo, Inc. | Daiichi Sankyo Co Ltd | In Review | 2020-10-12 | view |
JXSB2101024 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2021-06-15 | | | | | view |
JXSL2101093 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2021-08-13 | | | | | view |
JYSB1900293 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products | Supplementary Application | 2019-10-25 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd | Certificate Issued | 2019-12-27 | view |
JXSL2100011 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2021-01-25 | Daiichi Sankyo, Inc. | Daiichi Sankyo Co Ltd | In Review | 2021-01-25 | view |
JXSB2200068 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2022-06-13 | | | | | view |
JXSB2300103 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2023-08-24 | | | | | view |
JXSL2101064 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2021-07-02 | | | | | view |
JXSB2200044 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2022-04-22 | | | | | view |
JYSB1900257 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products | Supplementary Application | 2019-09-18 | 艾昆纬医药科技(上海)有限公司 | Aikunwei Medical Technology (Shanghai) Co Ltd | Certificate Issued | 2019-12-13 | view |
JXSB2400023 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2024-03-04 | | | | | view |
JXSB2100005 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2021-01-08 | | | In Review | 2021-01-07 | view |
JXSL2300149 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2023-08-02 | | | | | view |